Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Sell
32
GCTK Quote, Financials, Valuation and Earnings
Last price:
$5.99
Seasonality move
:
-19.7%
Day range:
$5.97 - $6.16
52-week range:
$4.22 - $467.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.72x
P/B ratio:
62.47x
Volume:
3.6K
Avg. volume:
26.7K
1-year change:
-98.07%
Market cap:
$171.9M
Revenue:
--
EPS (TTM):
-$1,319.98
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, GlucoTrack, Inc. has -- downside to fair value with a price target of -- per share.
GCTK vs. S&P 500
-
Over the past 5 trading days, GlucoTrack, Inc. has underperformed the S&P 500 by -12.04% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
GlucoTrack, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
GlucoTrack, Inc. revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter GlucoTrack, Inc. reported revenues of --.
Earnings Growth
-
GlucoTrack, Inc. earnings have been falling on a year-over-year basis for 9 quarters in a row. In the most recent quarter GlucoTrack, Inc. reported earnings per share of -$4.64.
Enterprise value:
167.3M
EV / Invested capital:
--
Price / LTM sales:
6.72x
EV / EBIT:
--
EV / Revenue:
750.44x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-11.24x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$42K
Return On Assets:
-370.72%
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
-2079.63%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$25K | -$22K | -$42K | -$10K | -$9K | |
| Operating Income | -$6M | -$13.1M | -$16.5M | -$3.3M | -$4.3M | |
| EBITDA | -$5.9M | -$13.1M | -$16.4M | -$3.2M | -$4.3M | |
| Diluted EPS | -$1.59 | -$2.89 | -$1,319.98 | -$0.91 | -$4.64 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $7.4M | $3.4M | $7.2M | $642K | $8.1M | |
| Total Assets | $7.6M | $3.5M | $7.2M | $826K | $8.3M | |
| Current Liabilities | $898K | $965K | $1.5M | $4.6M | $5.3M | |
| Total Liabilities | $1.1M | $1.2M | $1.6M | $4.8M | $5.5M | |
| Total Equity | $6.5M | $2.3M | $5.6M | -$4M | $2.8M | |
| Total Debt | $266K | $191K | $184K | $237K | $239K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$5.1M | -$11.4M | -$14.8M | -$4.1M | -$4.6M | |
| Cash From Investing | $5K | -$104K | -$76K | -$33K | -$67K | |
| Cash From Financing | $8.7M | $5M | $22.3M | $4.4M | $3M | |
| Free Cash Flow | -$5.1M | -$11.5M | -$14.9M | -$4.2M | -$4.7M | |
GCTK
Sector
Market Cap
$171.9M
$28.5M
Price % of 52-Week High
1.28%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
-10.83%
-1.33%
1-Year Price Total Return
-98.07%
-20.32%
Beta (5-Year)
0.300
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$6.04
200-day SMA
Sell
Level
$8.80
Bollinger Bands (100)
Sell
Level
5.11 - 7.23
Chaikin Money Flow
Sell
Level
-53.5M
20-day SMA
Buy
Level
$5.59
Relative Strength Index (RSI14)
Buy
Level
51.45
ADX Line
Buy
Level
18.46
Williams %R
Neutral
Level
-41.6667
50-day SMA
Sell
Level
$6.34
MACD (12, 26)
Sell
Level
-0.04
25-day Aroon Oscillator
Buy
Level
12
On Balance Volume
Neutral
Level
122.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-27.2139)
Sell
CA Score
(Annual)
Level (-19.0174)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (29.62)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.
Stock Forecast FAQ
In the current month, GCTK has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GCTK average analyst price target in the past 3 months is --.
-
Where Will GlucoTrack, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that GlucoTrack, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About GlucoTrack, Inc.?
Analysts are divided on their view about GlucoTrack, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that GlucoTrack, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is GlucoTrack, Inc.'s Price Target?
The price target for GlucoTrack, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is GCTK A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for GlucoTrack, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of GCTK?
You can purchase shares of GlucoTrack, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase GlucoTrack, Inc. shares.
-
What Is The GlucoTrack, Inc. Share Price Today?
GlucoTrack, Inc. was last trading at $5.99 per share. This represents the most recent stock quote for GlucoTrack, Inc.. Yesterday, GlucoTrack, Inc. closed at $6.00 per share.
-
How To Buy GlucoTrack, Inc. Stock Online?
In order to purchase GlucoTrack, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get GCTK Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GCTK
Sector
P/E ratio
--
23.75x
PEG ratio
0.00x
-0.01x
P/B ratio
62.47x
1.83x
Price / LTM sales
6.72x
1.60x
Growth Metrics
GCTK
Sector
Revenue growth
--
4.85%
Earnings growth
-410.06%
11.11%
Revenue (5-year growth)
-100%
6.45%
Earnings forecast
--
-$0.20
Profitability
GCTK
Sector
Profitability FY 2024
-$36K
$3.6M
Return on invested capital
-2079.63%
-30.98%
Return on assets
-370.72%
-27.62%
Return on equity
--
-36.69%
Earnings Date
Last Earnings Date
Dec
7
Next Earnings Date
Dec
7
Estimated Next Earnings Date
Mar
8
Balance Sheet
GCTK
Sector
Total cash
$7.9M
$27.2M
Short term investments
--
$25.7M
Total assets
$5.9M
$79.7M
Long term debt
$239K
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
